DALIMED’s SYMIX Dual-Chamber Syringe platform offers a purpose-built solution for stability-sensitive formulations like Leuprolide and Aripiprazole, enabling separate storage, in-device mixing, and direct injection from a single device.

DALI Medical Devices offers the SYMIX Dual-Chamber Syringe platform, specifically customized for Leuprolide and Aripiprazole injectable drugs.

Designed for stability-sensitive formulations, this system enables separate storage and in-device mixing, followed by direct injection from the same device. By consolidating the preparation process, SYMIX simplifies handling, reduces contamination risks, and supports the growing shift toward homecare use.

For more details, please contact: Ziv Cahani, VP Business Development: zcahani@dalimed.com